YAP1 Is Associated With Poor Prognosis and Cetuximab Resistance in CRC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Significant Association of Oncogene YAP1 With Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients
Clin. Cancer Res 2015 Jan 15;21(2)357-364, KW Lee, SS Lee, SB Kim, BH Sohn, HS Lee, HJ Jang, YY Park, S Kopetz, SS Kim, SC Oh, JS LeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.